Fundraising Fox

Philip Komarnitsky

Chief Medical Officer at Nested Therapeutics

Brookline, Massachusetts, United States

Find your path to Philip

328 people in our graph share verified history with Philip — schools, employers, funds. One of them is your warm intro.

Jeremy KirschunlockedPhilip: together at MIT Sloan School of Management (2002–2004)
×3Philip: together at MIT Sloan School of Management
Philip: together at AbbVie
Philip: together at Harvard Medical School

Chief Medical Officer at Nested Therapeutics

Intro paths

→

In turn, Philip can intro founders to Nested Therapeutics's investors below.

Nested Therapeutics's investors · 6

Cowen Healthcare InvestmentsNew York · since 2022Foresite CapitalWest Hollywood · since 2022Goldman SachsNew York · since 2022Section 32Palo Alto · since 2022Sixty Degree CapitalNorth YorkVersant VenturesSan Francisco · $250K – $5M checks

Co-founders at Nested Therapeutics

ADArvin Dar
Arvin DarCo-founder & Board Observer
KS
Kevan ShokatScientific Co-founder
KHKlaus Hoeflich
Klaus HoeflichCo-founder & former Chief Scientific Officer

Experience

  1. Nested TherapeuticsChief Medical Officercurrent2022 — presentCambridge, Massachusetts, United States
  2. Sumitomo Dainippon Pharma OncologyVice President, Head of Translational Medicine and Early Development2020 — 2022Cambridge, Massachusetts, United States
  3. AbbVieGroup Medical Director2018 — 2020Cambridge, United States
  4. AbbVieSenior Medical Director, Oncology Clinical Development2015 — 2018Cambridge, MA, USA
  5. AbbVieMedical Director2014 — 2015Cambridge, Massachusetts, United States
  6. AVEO OncologyMedical Director2012 — 2013Cambridge, MA
  7. EMD SeronoMedical Director, Oncology2009 — 2012
  8. Ziopharm Oncology IncAssociate Medical Director & Senior Director Project Management2008 — 2009
  9. Ziopharm Oncology IncDirector Technology Operations2006 — 2008
  10. Ziopharm Oncology IncAssociate Director Technology Operations2006
  11. Putnam AssociatesHelthcare strategy2005 — 2006
  12. Millennium PharmaceuticalsOncology drug discovery2000 — 2003
  13. Harvard Medical SchoolFellow1997 — 2000

Skills & more

Clinical1Oncology18Clinical Development21Biochemistry7Biotechnology10Clinical Research7Biologics1Biomarkers2Lifesciences5Medical Devices1Clinical Trials4

Languages English · Russian

From Philip's professional profile.

Frequently asked questions

Who is Philip Komarnitsky?
Chief Medical Officer at Nested Therapeutics
Where does Philip Komarnitsky work?
Philip Komarnitsky is Chief Medical Officer at Nested Therapeutics.
Where did Philip Komarnitsky go to school?
Philip Komarnitsky studied at MIT Sloan School of Management (MBA); University of New Hampshire (PhD, Biochemistry); The Russian State Medical University (MD, medicine).

Same school

Also attended MIT Sloan School of Management935

Doug LeonePartner at Sequoia Capital; former Global Managing PartnerHemant TanejaCEO & Managing Director of General CatalystBrad FeldCo-founder of Foundry and TechstarsChris MorrisProcess Specialist, Exit Readiness at Mayfair Equity PartnersBirgitteInvestor at InvestinorOlaInvestor at Investinor

+ 929 more

Also attended University of New Hampshire93

Jessica DowdInvestor at OpenView Venture PartnersRosemary SullivanOperations Manager at RET VenturesAndrew BrochuController at Castle Island VenturesBryce BlairAdvisory Board at Navitas CapitalChris StoneInvestor at EPIC VENTURESDillon HealyHead of Business Development & Capital Formation, North America at Sora Ventures

+ 87 more

Shared employers

Also worked at AbbVie67

Nick GasbarroChief of Staff at QED InvestorsCharles White, Ph.D.Principal at Illumina VenturesLaura QuockCBO-in-Residence at Versant VenturesManik PasrichaVice President at Titan CapitalJennifer SmoterChief Communications & Governance Officer at Takeda VenturesTakehiko SawabeDirector at Beyond Next Ventures

+ 61 more

Also worked at AVEO Oncology6

Jeno GyurisPartner at Cure VenturesMay HanPartner at Cure VenturesRaju KucherlapatiVenture Partner at Catalio Capital Management, LPMichael BorettiLeadership at SoluDavid JohnstonChief Financial Officer at Deep GenomicsJoseph D. VittiglioChief Business & Legal Officer and Secretary at PepGen

Also worked at EMD Serono31

Chris RobinsonInvestor at Third Rock VenturesRoel BulthuisInvestor at SynconaYvonne YamanakaPartner at venBio PartnersParis PanayiotopoulosSenior Managing Director at Blackstone Life SciencesKen MacLeodPartner at Rosetta Capital Ltd.Alicia Irurzun-LafittePartner at UCB Ventures

+ 25 more

Also worked at Putnam Associates21

Elena VibochManaging Director at General CatalystKathryn ReddyPrincipal at .406 VenturesTara SullivanPrincipal at Flare Capital PartnersJake BauerVenture Partner at ARCH Venture PartnersCharles White, Ph.D.Principal at Illumina VenturesPeter EmighFounder & President, Savoy Life at Red Cell Incubation

+ 15 more